Oncology Research Editorial Office

Oncology Research, Vol.34, No.9, 2026, DOI:10.32604/or.2026.090479 - 13 August 2026

Abstract This article has no abstract. More >

Oncology Research Editorial Office

Oncology Research, Vol.34, No.9, 2026, DOI:10.32604/or.2026.090478 - 13 August 2026

Abstract This article has no abstract. More >

Wen Gao^1,2, Xingyu Zheng^1,2, Yanan Hu^1,2, Rui Zou³, Yongan Zhou⁴, Xiang Song^2,*

Oncology Research, Vol.34, No.9, 2026, DOI:10.32604/or.2026.082652 - 13 August 2026

Abstract Background: As a core component of the immunoproteasome, the β1i subunit (proteasome 20S subunit beta 9, PSMB9) is involved in antigen processing and presentation and regulates anti-tumor immune responses. PSMB9 is aberrantly overexpressed in colorectal cancer. However, the precise mechanisms through which PSMB9 contributes to the initiation, progression, and immune regulation of colorectal cancer remain unclear. This study aims to investigate the expression characteristics and biological functions of PSMB9 in colorectal cancer, and to further elucidate the molecular pathways underlying its role in colorectal cancer initiation and progression. The findings are expected to provide a theoretical… More >

Oncology Research Editorial Office

Oncology Research, Vol.34, No.8, 2026, DOI:10.32604/or.2026.088697 - 16 July 2026

Abstract This article has no abstract. More >

Oncology Research Editorial Office

Oncology Research, Vol.34, No.7, 2026, DOI:10.32604/or.2026.086727 - 16 June 2026

Abstract This article has no abstract. More >

Oncology Research Editorial Office

Oncology Research, Vol.34, No.7, 2026, DOI:10.32604/or.2026.086722 - 16 June 2026

Abstract This article has no abstract. More >

Oncology Research Editorial Office

Oncology Research, Vol.34, No.7, 2026, DOI:10.32604/or.2026.086719 - 16 June 2026

Abstract This article has no abstract. More >

Zoe Bell¹, Corey D. Chan^1,2, Rachel Howarth³, Andrea Atkinson¹, Zakareya Gamie^1,4, Daniel Frankel⁵, Oana Bretcanu⁵, Kenneth S. Rankin^1,2,*

Oncology Research, Vol.34, No.7, 2026, DOI:10.32604/or.2026.075617 - 16 June 2026

Abstract Objectives: Chondrosarcoma is the most common type of primary bone sarcoma in adults with a high risk of local recurrence and metastasis. Chondrosarcomas are largely resistant to chemotherapy and radiotherapy, meaning that surgery is the mainstay of treatment for most patients. Therefore, new therapeutic targets are required. Cluster of differentiation 44 (CD44) is a transmembrane protein that has roles in cell proliferation, adhesion and migration and is shown to be overexpressed in several cancer types. Consequently, this work was undertaken to understand whether CD44 could be a potential therapeutic target in chondrosarcoma. Methods: In this study,… More > Graphic Abstract

Matteo Gentilini^1,2,3, Sofia Mangili², Alberto Selvaggi^4,5, Rodolfo Gentili^1,*, Brigitte Marazzi^2,3

Phyton-International Journal of Experimental Botany, Vol.95, No.5, 2026, DOI:10.32604/phyton.2026.078024 - 27 May 2026

Abstract Sorghum halepense (L.) Pers. (Johnson grass, Poaceae) is a worldwide problematic alien species, rapidly expanding its alien range in Europe. This study reconstructed the spread history, and assessed the current distribution, ecological traits, and invasion potential of this species in the Insubric region of northern Italy and southern Switzerland. Herbarium and occurrence data showed that its spread began in the late 19th century and has accelerated recently in the foothill zone, progressing northward and upward. High-cover populations occurred in anthropogenic habitats, especially ruderal and agricultural areas. Morphological analyses revealed statistically significant site-dependent differences in plant height… More >

Kaidi Yin, Lili Deng, Wen Liu^*

Oncology Research, Vol.34, No.6, 2026, DOI:10.32604/or.2026.075185 - 21 May 2026

Abstract Objectives: Although claudin-1 (CLDN1) interacts with Cluster of Differentiation 81 (CD81) in various cell types, the specific mechanism underlying this interaction and its functional implications in colorectal cancer (CRC) cells remain poorly understood. This study outlines the regulatory role of CLDN1 in CRC cell tumorigenicity through its interaction with CD81, elucidating the underlying signaling cascade. Methods: Changes in the expression of CLDN1 and CD81, as well as their correlation with the survival of CRC patients, were analyzed using samples from The Cancer Genome Atlas database, the Kaplan‒Meier plotter database, and tissue microarrays. CLDN1 and CD81 were… More >